DK2768527T3 - Multi-cbv-vaccine til at forebygge eller behandle type 1-diabetes - Google Patents
Multi-cbv-vaccine til at forebygge eller behandle type 1-diabetesInfo
- Publication number
- DK2768527T3 DK2768527T3 DK12775490.1T DK12775490T DK2768527T3 DK 2768527 T3 DK2768527 T3 DK 2768527T3 DK 12775490 T DK12775490 T DK 12775490T DK 2768527 T3 DK2768527 T3 DK 2768527T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes
- preventing
- treating type
- cbv
- vaccine
- Prior art date
Links
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306344.0A EP2583688A1 (en) | 2011-10-18 | 2011-10-18 | Multi-CBV vaccine for preventing or treating type 1 diabetes |
| PCT/EP2012/070653 WO2013057191A1 (en) | 2011-10-18 | 2012-10-18 | Multi-cbv vaccine for preventing or treating type 1 diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2768527T3 true DK2768527T3 (da) | 2017-11-06 |
Family
ID=47049165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12775490.1T DK2768527T3 (da) | 2011-10-18 | 2012-10-18 | Multi-cbv-vaccine til at forebygge eller behandle type 1-diabetes |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US20140255425A1 (da) |
| EP (2) | EP2583688A1 (da) |
| DK (1) | DK2768527T3 (da) |
| ES (1) | ES2643696T3 (da) |
| PL (1) | PL2768527T3 (da) |
| WO (1) | WO2013057191A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2583688A1 (en) | 2011-10-18 | 2013-04-24 | Sanofi Pasteur | Multi-CBV vaccine for preventing or treating type 1 diabetes |
| WO2023076856A1 (en) * | 2021-10-25 | 2023-05-04 | Provention Bio, Inc. | Coxsackievirus b compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1187631E (pt) | 1999-06-24 | 2005-01-31 | Heikki Hyoty | Prevencao de diabetes de tipo 1 e de outras doencas provocadas por enterovirus nao-polio |
| US20100047273A1 (en) | 2007-05-07 | 2010-02-25 | Rino Rappuoli | Coxsackie B virus and type 1 diabetes |
| DE102009034553A1 (de) * | 2009-07-23 | 2011-01-27 | Oerter, Detlef, Dr. | Impfstoff zur Prävention von akuter lymphoblastischer Leukämie bei Kindern |
| EP2583688A1 (en) * | 2011-10-18 | 2013-04-24 | Sanofi Pasteur | Multi-CBV vaccine for preventing or treating type 1 diabetes |
-
2011
- 2011-10-18 EP EP11306344.0A patent/EP2583688A1/en not_active Withdrawn
-
2012
- 2012-10-18 ES ES12775490.1T patent/ES2643696T3/es active Active
- 2012-10-18 DK DK12775490.1T patent/DK2768527T3/da active
- 2012-10-18 US US14/352,585 patent/US20140255425A1/en not_active Abandoned
- 2012-10-18 EP EP12775490.1A patent/EP2768527B1/en active Active
- 2012-10-18 PL PL12775490T patent/PL2768527T3/pl unknown
- 2012-10-18 WO PCT/EP2012/070653 patent/WO2013057191A1/en active Application Filing
-
2017
- 2017-03-22 US US15/465,854 patent/US10258685B2/en active Active
-
2019
- 2019-02-01 US US16/265,681 patent/US10780157B2/en active Active
- 2019-02-01 US US16/265,677 patent/US10675344B2/en active Active
-
2020
- 2020-08-17 US US16/995,439 patent/US11633468B2/en active Active
-
2021
- 2021-04-07 US US17/224,430 patent/US11911456B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10258685B2 (en) | 2019-04-16 |
| US20190209675A1 (en) | 2019-07-11 |
| EP2583688A9 (en) | 2013-10-09 |
| US11911456B2 (en) | 2024-02-27 |
| EP2768527B1 (en) | 2017-08-09 |
| US20210023196A1 (en) | 2021-01-28 |
| EP2768527A1 (en) | 2014-08-27 |
| PL2768527T3 (pl) | 2017-12-29 |
| US11633468B2 (en) | 2023-04-25 |
| US20210220465A1 (en) | 2021-07-22 |
| US20140255425A1 (en) | 2014-09-11 |
| EP2583688A1 (en) | 2013-04-24 |
| US20200000908A1 (en) | 2020-01-02 |
| US20170281748A1 (en) | 2017-10-05 |
| ES2643696T3 (es) | 2017-11-23 |
| WO2013057191A1 (en) | 2013-04-25 |
| US10780157B2 (en) | 2020-09-22 |
| US10675344B2 (en) | 2020-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013020613A2 (pt) | autoinjetor | |
| DK3269802T3 (da) | Forbindelser til forbedret virustransduktion | |
| DK2707029T3 (da) | Fremgangsmåder til at behandle eller forebygge kolesterolrelaterede sygdomme | |
| BR112013015783A2 (pt) | autoinjetor. | |
| DK2741763T3 (da) | Sammensætning til kontrolleret ovariestimulering. | |
| BR112014009889A2 (pt) | compostos dissubstituídos, compostos e composição farmacêutica | |
| DK3138916T3 (da) | Immunogen sammensætning | |
| UA26516S (uk) | Пристрій для ін'єкцій | |
| ITMI20120696A1 (it) | Ventilconvettore. | |
| DK2788353T3 (da) | Bur-aminligander til metallo-radiofarmaceutika | |
| BR112013030897A2 (pt) | composição. | |
| DK2748147T3 (da) | Substitueret 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinolin-4-carboxamider til antimalaria-terapier | |
| FI20125806A (fi) | Jonotusmenetelmä | |
| DK3427723T3 (da) | Rna-formulering til immunterapi | |
| DK2745928T3 (da) | Fremgangsmåde til emulsionsfremstilling | |
| FI20110092A (fi) | Hunajalinko | |
| DK2768527T3 (da) | Multi-cbv-vaccine til at forebygge eller behandle type 1-diabetes | |
| FI20116047L (fi) | Menetelmä terveyskortin hallinnoimiseksi | |
| DK2731630T3 (da) | Autoklav til medicinsk-dental anvendelse | |
| SG11201501289TA (en) | Preparation for preventing or treating type i diabetes | |
| FR2990866B1 (fr) | Autoinjecteur | |
| FR2990867B1 (fr) | Autoinjecteur | |
| FR2990865B1 (fr) | Autoinjecteur | |
| ES2396651B2 (es) | Material biosanitario antiulcera. | |
| ES2859675T8 (es) | Sensor y procedimiento para operar el sensor |